Economic burden and the cost-effectiveness of treatment of cardiovascular diseases in Africa

Heart
T A Gaziano

Abstract

Cardiovascular disease is the leading cause of death in those over the age of 45 in Africa. The economic toll from cardiovascular diseases is equally devastating, leading to billions of dollars lost due to healthcare costs and reduced productivity from the disabling and fatal outcomes related to diabetes, hypertension, stroke, valvular heart disease, and heart failure. Much of it is preventable. With reasonable screening programmes and judicious use of scarce resources much of the suffering can be alleviated. This article reviews the economic burden attributable to cardiovascular disease in Africa and many of the potential cost-effective solutions to the large burden. It further outlines many of the areas where we know less and must focus our future research in trying to outline cost-effective solutions.

Citations

Dec 22, 2010·European Journal of Nuclear Medicine and Molecular Imaging·Pasquale Perrone-FilardiAlberto Cuocolo
Jul 11, 2012·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Nikos ManiadakisJohn Kyriopoulos
Jul 27, 2011·European Journal of Cardiovascular Nursing : Journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology·Christi DeatonTiny Jaarsma
Apr 10, 2013·Asian Pacific Journal of Tropical Biomedicine·P PrahalathanB Raja
Jul 9, 2008·Nature Clinical Practice. Cardiovascular Medicine·Rajesh Vedanthan, Valentin Fuster
Jun 18, 2011·The Journal of Cardiovascular Nursing·Christi DeatonTiny Jaarsma
Apr 19, 2013·Cardiovascular Ultrasound·Zhi-Yi ChenShu ping Ge
Dec 12, 2012·Cost Effectiveness and Resource Allocation : C/E·Lester Sam Araneta Geroy
Jul 19, 2012·International Journal of General Medicine·Shashi K Agarwal
Sep 9, 2011·Cardiovascular Journal of Africa·Andre Pascal KengneBongani M Mayosi
Sep 10, 2009·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Luisa Soares-MirandaJorge Mota
Jan 12, 2011·Annual Review of Public Health·Kaustubh C DabhadkarK M Venkat Narayan
Apr 21, 2009·Nature Reviews. Cardiology·Rajesh Vedanthan, Valentin Fuster
Mar 1, 2012·International Health·Thomas SchwartzIvar Sjaastad
Aug 21, 2015·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Chongke ZhongYonghong Zhang
Aug 13, 2014·Health Policy and Planning·Frida NgalesoniBjarne Robberstad
Mar 20, 2012·Revue D'épidémiologie Et De Santé Publique·T Lang
Aug 20, 2016·Nigerian Journal of Clinical Practice·O Q BakareA Osibogun
Oct 27, 2017·Systematic Reviews·Leonard BaatiemaShawn Somerset
Apr 20, 2011·Circulation·Valentin FusterRajesh Vedanthan
Oct 12, 2017·BMJ Global Health·David J Heller, Sandeep P Kishore
Jul 22, 2009·Clinical Pharmacology and Therapeutics·S A Holstein, R J Hohl
Jul 10, 2017·The International Journal of Occupational and Environmental Medicine·Rasool MohammadiHamid Soori
Apr 3, 2020·International Journal of Environmental Research and Public Health·Javad Sharifi-RadDaniela Calina
Jun 3, 2017·Korean journal of family medicine·Karimé GonzálezJosé Luis Márquez
Dec 12, 2020·Expert Review of Cardiovascular Therapy·Nasheeta PeerAndre-Pascal Kengne
Feb 10, 2021·Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)·Johnson Oluwaseun OdukoyaDerek Tantoh Ndinteh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.